# Outcome of Second Generation Drug-eLuting Stents in Patients With Diabetes Mellitus

> **NCT01293773** · PHASE4 · WITHDRAWN · sponsor: **Policlinico Casilino ASL RMB**

## Conditions studied

- Coronary Artery Disease
- Diabetes Mellitus

## Interventions

- **DEVICE:** Taxus Element stent
- **DEVICE:** Integrity Resolute stent
- **DEVICE:** Xience Prime stent

## Key facts

- **NCT ID:** NCT01293773
- **Lead sponsor:** Policlinico Casilino ASL RMB
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2010-10
- **Primary completion:** 2012-10
- **Final completion:** 2012-12
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2014-11-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01293773

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01293773, "Outcome of Second Generation Drug-eLuting Stents in Patients With Diabetes Mellitus". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT01293773. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*